TD Cowen analyst Ryan Langston lowered the firm’s price target on Universal Health (UHS) to $251 from $275 and keeps a Buy rating on the shares. The firm said UHS is a best idea for 2025. The incoming administration and market sentiment add risk to the pick and acknowledge the potential for revisions to entitlement programs and other headwinds. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on Tip
Health